www.tempesttx.com Open in urlscan Pro
69.63.141.106  Public Scan

Form analysis
0 forms found in the DOM

Text Content

INNOVATIVE TARGETED AND IMMUNE-MEDIATED CANCER THERAPIES


PIPELINE

> Developing first-in-class small molecule product candidates with broad
> potential benefit to patients
> 
> Learn more


SCIENCE

> Modulating validated and new pathways to develop novel therapeutics
> 
> Learn more


NEWS

November 8, 2023
Tempest Reports Third Quarter 2023 Financial Results and Provides Business
Update

October 11, 2023
Tempest Adopts Limited Duration Stockholder Rights Plan

October 11, 2023
Tempest Releases New Data Demonstrating Superiority of TPST-1120 Arm Across
Multiple Study Endpoints in Randomized First-Line HCC Study

More news


EVENTS

Wednesday, October 11TH, 2023 at 8:30 AM Eastern
TPST-1120 Global Randomized Phase 1b/2 Combination Study Data Call
Listen: Webcast
Download: Presentation [pdf]

Monday, September 11TH, 2023 at 7:00 AM Eastern
H.C. Wainwright 25th Annual Global Investment Conference
Listen: Webcast

 * Home
 * About
 * Pipeline
 * Science
 * Publications
 * Investors
    * News & Events
    * Stock Information
    * Corporate Governance
    * Financials & Filings
    * Investor Resources

 * Careers
 * Contact Us

© 2023 Tempest Therapeutics, Inc. All rights reserved.Website Design: Hane Chow,
Inc.